BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15890953)

  • 1. Characterization of human immunodeficiency virus Gag-specific gamma interferon-expressing cells following protective mucosal immunization with alphavirus replicon particles.
    Gupta S; Janani R; Bin Q; Luciw P; Greer C; Perri S; Legg H; Donnelly J; Barnett S; O'Hagan D; Polo JM; Vajdy M
    J Virol; 2005 Jun; 79(11):7135-45. PubMed ID: 15890953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-mediated protection against mucosal simian-human immunodeficiency virus challenge of macaques immunized with alphavirus replicon particles and boosted with trimeric envelope glycoprotein in MF59 adjuvant.
    Barnett SW; Burke B; Sun Y; Kan E; Legg H; Lian Y; Bost K; Zhou F; Goodsell A; Zur Megede J; Polo J; Donnelly J; Ulmer J; Otten GR; Miller CJ; Vajdy M; Srivastava IK
    J Virol; 2010 Jun; 84(12):5975-85. PubMed ID: 20392857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A chimeric alphavirus replicon particle vaccine expressing the hemagglutinin and fusion proteins protects juvenile and infant rhesus macaques from measles.
    Pan CH; Greer CE; Hauer D; Legg HS; Lee EY; Bergen MJ; Lau B; Adams RJ; Polo JM; Griffin DE
    J Virol; 2010 Apr; 84(8):3798-807. PubMed ID: 20130066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of novel type I interferon epsilon in viral infection and mucosal immunity.
    Xi Y; Day SL; Jackson RJ; Ranasinghe C
    Mucosal Immunol; 2012 Nov; 5(6):610-22. PubMed ID: 22617838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic, mucosal, and heterotypic immune induction in mice inoculated with Venezuelan equine encephalitis replicons expressing Norwalk virus-like particles.
    Harrington PR; Yount B; Johnston RE; Davis N; Moe C; Baric RS
    J Virol; 2002 Jan; 76(2):730-42. PubMed ID: 11752163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the two major envelope proteins of equine arteritis virus as a heterodimer is necessary for induction of neutralizing antibodies in mice immunized with recombinant Venezuelan equine encephalitis virus replicon particles.
    Balasuriya UB; Heidner HW; Hedges JF; Williams JC; Davis NL; Johnston RE; MacLachlan NJ
    J Virol; 2000 Nov; 74(22):10623-30. PubMed ID: 11044106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infection of human dendritic cells by a sindbis virus replicon vector is determined by a single amino acid substitution in the E2 glycoprotein.
    Gardner JP; Frolov I; Perri S; Ji Y; MacKichan ML; zur Megede J; Chen M; Belli BA; Driver DA; Sherrill S; Greer CE; Otten GR; Barnett SW; Liu MA; Dubensky TW; Polo JM
    J Virol; 2000 Dec; 74(24):11849-57. PubMed ID: 11090185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of disease, T cell responses, and measles virus clearance in monkeys vaccinated with H-encoding alphavirus replicon particles.
    Pan CH; Valsamakis A; Colella T; Nair N; Adams RJ; Polack FP; Greer CE; Perri S; Polo JM; Griffin DE
    Proc Natl Acad Sci U S A; 2005 Aug; 102(33):11581-8. PubMed ID: 16037211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-cell Epitopes Identified by BALB/c Mice Immunized with Vaccinia Expressing HIV-1 Gag lie within immunodominant Regions Recognized by HIV-infected Indian Patients.
    Shete AV; Thakar MR; Tripathy SP; Raut C; Chakrabarti S; Paranjape RS
    J Glob Infect Dis; 2011 Jul; 3(3):246-53. PubMed ID: 21887056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Channeling the Natural Properties of Sindbis Alphavirus for Targeted Tumor Therapy.
    Pampeno C; Hurtado A; Opp S; Meruelo D
    Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical trials of self-replicating RNA-based cancer vaccines.
    Morse MA; Crosby EJ; Force J; Osada T; Hobeika AC; Hartman ZC; Berglund P; Smith J; Lyerly HK
    Cancer Gene Ther; 2023 Jun; 30(6):803-811. PubMed ID: 36765179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mRNA vaccines: a new opportunity for malaria, tuberculosis and HIV.
    Matarazzo L; Bettencourt PJG
    Front Immunol; 2023; 14():1172691. PubMed ID: 37168860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal vaccine delivery: A focus on the breakthrough of specific barriers.
    Huang M; Zhang M; Zhu H; Du X; Wang J
    Acta Pharm Sin B; 2022 Sep; 12(9):3456-3474. PubMed ID: 35818435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaginal delivery of vaccines.
    VanBenschoten HM; Woodrow KA
    Adv Drug Deliv Rev; 2021 Nov; 178():113956. PubMed ID: 34481031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal Vaccine Approaches for Prevention of HIV and SIV Transmission.
    Kozlowski PA; Aldovini A
    Curr Immunol Rev; 2019; 15(1):102-122. PubMed ID: 31452652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genital Chlamydia trachomatis: understanding the roles of innate and adaptive immunity in vaccine research.
    Vasilevsky S; Greub G; Nardelli-Haefliger D; Baud D
    Clin Microbiol Rev; 2014 Apr; 27(2):346-70. PubMed ID: 24696438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An effective vaccination approach augments anti-HIV systemic and vaginal immunity in mice with decreased HIV-1 susceptible α4β7high CD4+ T cells.
    Zhu W; Shi G; Tang H; Lewis DE; Song XT
    Curr HIV Res; 2013 Jan; 11(1):56-66. PubMed ID: 23157585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of interference with immunogenicity of a chimeric alphavirus replicon particle-based influenza vaccine by preexisting antivector immunity.
    Uematsu Y; Vajdy M; Lian Y; Perri S; Greer CE; Legg HS; Galli G; Saletti G; Otten GR; Rappuoli R; Barnett SW; Polo JM
    Clin Vaccine Immunol; 2012 Jul; 19(7):991-8. PubMed ID: 22623651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A neonatal Fc receptor-targeted mucosal vaccine strategy effectively induces HIV-1 antigen-specific immunity to genital infection.
    Lu L; Palaniyandi S; Zeng R; Bai Y; Liu X; Wang Y; Pauza CD; Roopenian DC; Zhu X
    J Virol; 2011 Oct; 85(20):10542-53. PubMed ID: 21849464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parenteral is more efficient than mucosal immunization to induce regression of human papillomavirus-associated genital tumors.
    Decrausaz L; Domingos-Pereira S; Duc M; Bobst M; Romero P; Schiller JT; Jichlinski P; Nardelli-Haefliger D
    Int J Cancer; 2011 Aug; 129(3):762-72. PubMed ID: 21384340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.